Which of the following is NOT a csDMARD example?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Dermatology Week 1 Exam with comprehensive study materials. Practice with detailed questions, flashcards, and expert explanations. Boost your knowledge and confidence for the exam!

Multiple Choice

Which of the following is NOT a csDMARD example?

Explanation:
csDMARDs are conventional synthetic disease-modifying antirheumatic drugs—traditional small-molecule therapies taken to slow disease progression. Methotrexate, hydroxychloroquine, and leflunomide are classic examples of csDMARDs: they’re generally oral (or simple injections) medicines that broadly dampen the immune response over time. Infliximab, on the other hand, is a biologic DMARD. It’s a monoclonal antibody that targets TNF-alpha and is given by infusion. Biologic DMARDs are larger, protein-based therapies produced through biological processes and are not considered conventional synthetic drugs. So infliximab is not a csDMARD.

csDMARDs are conventional synthetic disease-modifying antirheumatic drugs—traditional small-molecule therapies taken to slow disease progression. Methotrexate, hydroxychloroquine, and leflunomide are classic examples of csDMARDs: they’re generally oral (or simple injections) medicines that broadly dampen the immune response over time. Infliximab, on the other hand, is a biologic DMARD. It’s a monoclonal antibody that targets TNF-alpha and is given by infusion. Biologic DMARDs are larger, protein-based therapies produced through biological processes and are not considered conventional synthetic drugs. So infliximab is not a csDMARD.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy